APO Research
Talk to an analyst

APO RESEARCH · REPORT

Injected Veterinary Pain Management Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Injected Veterinary Pain Management Drugs Industry Research Report 2026

22 December 2025126 pages

Choose your research edition.

Industry ResearchInjected Veterinary Pain Management Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Injected Veterinary Pain Management Drugs Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Injected Veterinary Pain Management Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injected Veterinary Pain Management Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Injected Veterinary Pain Management Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Injected Veterinary Pain Management Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Injected Veterinary Pain Management Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Injected Veterinary Pain Management Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Injected Veterinary Pain Management Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Injected Veterinary Pain Management Drugs include Zoetis, Merck & Co, Medtronic, Lilly, Baxter, Norbrook Laboratories, Halyard, Forest Laboratories and Endo International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Injected Veterinary Pain Management Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Injected Veterinary Pain Management Drugs Market by Company

Zoetis

Merck & Co

Medtronic

Lilly

Baxter

Norbrook Laboratories

Halyard

Forest Laboratories

Endo International

Elanco

Ceva Sante Animale

Bostonscientific

Boehringer Ingelheim

Bayer Pharma AG

Injected Veterinary Pain Management Drugs Segment by Type

Sedatives

Local Anesthetics

Nonsteroidal Anti-Inflammatory Drugs (NSIDs)

Opioids

α2-Adrenergic Agonists

Other

Injected Veterinary Pain Management Drugs Segment by Application

Veterinary Clinics

Veterinary Hospitals

For Retail

Others

Injected Veterinary Pain Management Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injected Veterinary Pain Management Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injected Veterinary Pain Management Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injected Veterinary Pain Management Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Injected Veterinary Pain Management Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Injected Veterinary Pain Management Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Injected Veterinary Pain Management Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Injected Veterinary Pain Management Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Injected Veterinary Pain Management Drugs Sales (k units) of Manufacturers (2021-2026) Table 7. Global Injected Veterinary Pain Management Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Injected Veterinary Pain Management Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Injected Veterinary Pain Management Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Injected Veterinary Pain Management Drugs Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Injected Veterinary Pain Management Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Injected Veterinary Pain Management Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Injected Veterinary Pain Management Drugs, Product Type & Application Table 14. Global Injected Veterinary Pain Management Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Injected Veterinary Pain Management Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zoetis Company Information Table 19. Zoetis Business Overview Table 20. Zoetis Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Zoetis Injected Veterinary Pain Management Drugs Product Portfolio Table 22. Zoetis Recent Developments Table 23. Merck & Co Company Information Table 24. Merck & Co Business Overview Table 25. Merck & Co Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Merck & Co Injected Veterinary Pain Management Drugs Product Portfolio Table 27. Merck & Co Recent Developments Table 28. Medtronic Company Information Table 29. Medtronic Business Overview Table 30. Medtronic Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Medtronic Injected Veterinary Pain Management Drugs Product Portfolio Table 32. Medtronic Recent Developments Table 33. Lilly Company Information Table 34. Lilly Business Overview Table 35. Lilly Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Lilly Injected Veterinary Pain Management Drugs Product Portfolio Table 37. Lilly Recent Developments Table 38. Baxter Company Information Table 39. Baxter Business Overview Table 40. Baxter Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Baxter Injected Veterinary Pain Management Drugs Product Portfolio Table 42. Baxter Recent Developments Table 43. Norbrook Laboratories Company Information Table 44. Norbrook Laboratories Business Overview Table 45. Norbrook Laboratories Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Norbrook Laboratories Injected Veterinary Pain Management Drugs Product Portfolio Table 47. Norbrook Laboratories Recent Developments Table 48. Halyard Company Information Table 49. Halyard Business Overview Table 50. Halyard Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Halyard Injected Veterinary Pain Management Drugs Product Portfolio Table 52. Halyard Recent Developments Table 53. Forest Laboratories Company Information Table 54. Forest Laboratories Business Overview Table 55. Forest Laboratories Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Forest Laboratories Injected Veterinary Pain Management Drugs Product Portfolio Table 57. Forest Laboratories Recent Developments Table 58. Endo International Company Information Table 59. Endo International Business Overview Table 60. Endo International Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Endo International Injected Veterinary Pain Management Drugs Product Portfolio Table 62. Endo International Recent Developments Table 63. Elanco Company Information Table 64. Elanco Business Overview Table 65. Elanco Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Elanco Injected Veterinary Pain Management Drugs Product Portfolio Table 67. Elanco Recent Developments Table 68. Ceva Sante Animale Company Information Table 69. Ceva Sante Animale Business Overview Table 70. Ceva Sante Animale Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Ceva Sante Animale Injected Veterinary Pain Management Drugs Product Portfolio Table 72. Ceva Sante Animale Recent Developments Table 73. Bostonscientific Company Information Table 74. Bostonscientific Business Overview Table 75. Bostonscientific Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Bostonscientific Injected Veterinary Pain Management Drugs Product Portfolio Table 77. Bostonscientific Recent Developments Table 78. Boehringer Ingelheim Company Information Table 79. Boehringer Ingelheim Business Overview Table 80. Boehringer Ingelheim Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Boehringer Ingelheim Injected Veterinary Pain Management Drugs Product Portfolio Table 82. Boehringer Ingelheim Recent Developments Table 83. Bayer Pharma AG Company Information Table 84. Bayer Pharma AG Business Overview Table 85. Bayer Pharma AG Injected Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Bayer Pharma AG Injected Veterinary Pain Management Drugs Product Portfolio Table 87. Bayer Pharma AG Recent Developments Table 88. Global Injected Veterinary Pain Management Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Injected Veterinary Pain Management Drugs Sales by Region (2021-2026) & (k units) Table 90. Global Injected Veterinary Pain Management Drugs Sales Market Share by Region (2021-2026) Table 91. Global Injected Veterinary Pain Management Drugs Sales by Region (2027-2032) & (k units) Table 92. Global Injected Veterinary Pain Management Drugs Sales Market Share by Region (2027-2032) Table 93. Global Injected Veterinary Pain Management Drugs Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Injected Veterinary Pain Management Drugs Revenue Market Share by Region (2021-2026) Table 95. Global Injected Veterinary Pain Management Drugs Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Injected Veterinary Pain Management Drugs Revenue Market Share by Region (2027-2032) Table 97. North America Injected Veterinary Pain Management Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Injected Veterinary Pain Management Drugs Sales by Country (2021-2026) & (k units) Table 99. North America Injected Veterinary Pain Management Drugs Sales by Country (2027-2032) & (k units) Table 100. North America Injected Veterinary Pain Management Drugs Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Injected Veterinary Pain Management Drugs Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Injected Veterinary Pain Management Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Injected Veterinary Pain Management Drugs Sales by Country (2021-2026) & (k units) Table 104. Europe Injected Veterinary Pain Management Drugs Sales by Country (2027-2032) & (k units) Table 105. Europe Injected Veterinary Pain Management Drugs Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Injected Veterinary Pain Management Drugs Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Injected Veterinary Pain Management Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Injected Veterinary Pain Management Drugs Sales by Country (2021-2026) & (k units) Table 109. Asia Pacific Injected Veterinary Pain Management Drugs Sales by Country (2027-2032) & (k units) Table 110. Asia Pacific Injected Veterinary Pain Management Drugs Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Injected Veterinary Pain Management Drugs Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Injected Veterinary Pain Management Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Injected Veterinary Pain Management Drugs Sales by Country (2021-2026) & (k units) Table 114. South America Injected Veterinary Pain Management Drugs Sales by Country (2027-2032) & (k units) Table 115. South America Injected Veterinary Pain Management Drugs Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Injected Veterinary Pain Management Drugs Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Injected Veterinary Pain Management Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Injected Veterinary Pain Management Drugs Sales by Country (2021-2026) & (k units) Table 119. Middle East and Africa Injected Veterinary Pain Management Drugs Sales by Country (2027-2032) & (k units) Table 120. Middle East and Africa Injected Veterinary Pain Management Drugs Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Injected Veterinary Pain Management Drugs Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Injected Veterinary Pain Management Drugs Sales by Type (2021-2026) & (k units) Table 123. Global Injected Veterinary Pain Management Drugs Sales by Type (2027-2032) & (k units) Table 124. Global Injected Veterinary Pain Management Drugs Sales Market Share by Type (2021-2026) Table 125. Global Injected Veterinary Pain Management Drugs Sales Market Share by Type (2027-2032) Table 126. Global Injected Veterinary Pain Management Drugs Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Injected Veterinary Pain Management Drugs Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Injected Veterinary Pain Management Drugs Revenue Market Share by Type (2021-2026) Table 129. Global Injected Veterinary Pain Management Drugs Revenue Market Share by Type (2027-2032) Table 130. Global Injected Veterinary Pain Management Drugs Price by Type (2021-2026) & (US$/unit) Table 131. Global Injected Veterinary Pain Management Drugs Price by Type (2027-2032) & (US$/unit) Table 132. Global Injected Veterinary Pain Management Drugs Sales by Application (2021-2026) & (k units) Table 133. Global Injected Veterinary Pain Management Drugs Sales by Application (2027-2032) & (k units) Table 134. Global Injected Veterinary Pain Management Drugs Sales Market Share by Application (2021-2026) Table 135. Global Injected Veterinary Pain Management Drugs Sales Market Share by Application (2027-2032) Table 136. Global Injected Veterinary Pain Management Drugs Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Injected Veterinary Pain Management Drugs Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Injected Veterinary Pain Management Drugs Revenue Market Share by Application (2021-2026) Table 139. Global Injected Veterinary Pain Management Drugs Revenue Market Share by Application (2027-2032) Table 140. Global Injected Veterinary Pain Management Drugs Price by Application (2021-2026) & (US$/unit) Table 141. Global Injected Veterinary Pain Management Drugs Price by Application (2027-2032) & (US$/unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Injected Veterinary Pain Management Drugs Distributors List Table 145. Injected Veterinary Pain Management Drugs Customers List Table 146. Injected Veterinary Pain Management Drugs Industry Trends Table 147. Injected Veterinary Pain Management Drugs Industry Drivers Table 148. Injected Veterinary Pain Management Drugs Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Injected Veterinary Pain Management Drugs Product Image Figure 5. Global Injected Veterinary Pain Management Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Injected Veterinary Pain Management Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Injected Veterinary Pain Management Drugs Sales (2021-2032) & (k units) Figure 8. Global Injected Veterinary Pain Management Drugs Average Price (US$/unit) & (2021-2032) Figure 9. Sedatives Product Image Figure 10. Local Anesthetics Product Image Figure 11. Nonsteroidal Anti-Inflammatory Drugs (NSIDs) Product Image Figure 12. Opioids Product Image Figure 13. α2-Adrenergic Agonists Product Image Figure 14. Other Product Image Figure 15. Veterinary Clinics Product Image Figure 16. Veterinary Hospitals Product Image Figure 17. For Retail Product Image Figure 18. Others Product Image Figure 19. Global Injected Veterinary Pain Management Drugs Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Injected Veterinary Pain Management Drugs, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Injected Veterinary Pain Management Drugs Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Injected Veterinary Pain Management Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Injected Veterinary Pain Management Drugs Sales by Region in 2025 Figure 25. Global Injected Veterinary Pain Management Drugs Revenue by Region in 2025 Figure 26. North America Injected Veterinary Pain Management Drugs Market Size by Country in 2025 Figure 27. North America Injected Veterinary Pain Management Drugs Sales Market Share by Country (2021-2032) Figure 28. North America Injected Veterinary Pain Management Drugs Revenue Market Share by Country (2021-2032) Figure 29. United States Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Mexico Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Europe Injected Veterinary Pain Management Drugs Market Size by Country in 2025 Figure 33. Europe Injected Veterinary Pain Management Drugs Sales Market Share by Country (2021-2032) Figure 34. Europe Injected Veterinary Pain Management Drugs Revenue Market Share by Country (2021-2032) Figure 35. Germany Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. France Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. U.K. Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Italy Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Russia Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Spain Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Netherlands Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Switzerland Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Sweden Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Poland Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Asia Pacific Injected Veterinary Pain Management Drugs Market Size by Country in 2025 Figure 46. Asia Pacific Injected Veterinary Pain Management Drugs Sales Market Share by Country (2021-2032) Figure 47. Asia Pacific Injected Veterinary Pain Management Drugs Revenue Market Share by Country (2021-2032) Figure 48. China Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Japan Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South Korea Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. India Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Australia Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Taiwan Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. South America Injected Veterinary Pain Management Drugs Market Size by Country in 2025 Figure 57. South America Injected Veterinary Pain Management Drugs Sales Market Share by Country (2021-2032) Figure 58. South America Injected Veterinary Pain Management Drugs Revenue Market Share by Country (2021-2032) Figure 59. Brazil Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Argentina Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Chile Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Middle East and Africa Injected Veterinary Pain Management Drugs Market Size by Country in 2025 Figure 63. Middle East and Africa Injected Veterinary Pain Management Drugs Sales Market Share by Country (2021-2032) Figure 64. Middle East and Africa Injected Veterinary Pain Management Drugs Revenue Market Share by Country (2021-2032) Figure 65. Egypt Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. South Africa Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Israel Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Türkiye Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. GCC Countries Injected Veterinary Pain Management Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Global Injected Veterinary Pain Management Drugs Sales Market Share by Type (2021-2032) Figure 71. Global Injected Veterinary Pain Management Drugs Revenue Market Share by Type (2021-2032) Figure 72. Global Injected Veterinary Pain Management Drugs Price (US$/unit) by Type (2021-2032) Figure 73. Global Injected Veterinary Pain Management Drugs Sales Market Share by Application (2021-2032) Figure 74. Global Injected Veterinary Pain Management Drugs Revenue Market Share by Application (2021-2032) Figure 75. Global Injected Veterinary Pain Management Drugs Price (US$/unit) by Application (2021-2032) Figure 76. Injected Veterinary Pain Management Drugs Value Chain Figure 77. Injected Veterinary Pain Management Drugs Production Mode & Process Figure 78. Direct Comparison with Distribution Share Figure 79. Distributors Profiles Figure 80. Injected Veterinary Pain Management Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Sedatives
  • Local Anesthetics
  • Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
  • Opioids
  • α2-Adrenergic Agonists
  • Other
Applications
  • Veterinary Clinics
  • Veterinary Hospitals
  • For Retail
  • Others
Companies covered
  • Zoetis
  • Merck & Co
  • Medtronic
  • Lilly
  • Baxter
  • Norbrook Laboratories
  • Halyard
  • Forest Laboratories
  • Endo International
  • Elanco
  • Ceva Sante Animale
  • Bostonscientific
  • Boehringer Ingelheim
  • Bayer Pharma AG

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Injected Veterinary Pain Management Drugs Market Size (2021-2032)
  4. 2.2.2 Global Injected Veterinary Pain Management Drugs Sales (2021-2032)
  5. 2.2.3 Global Injected Veterinary Pain Management Drugs Market Average Price (2021-2032)
  6. 2.3 Injected Veterinary Pain Management Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Sedatives
  9. 2.3.3 Local Anesthetics
  10. 2.3.4 Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
  11. 2.3.5 Opioids
  12. 2.3.6 α2-Adrenergic Agonists
  13. 2.3.7 Other
  14. 2.4 Injected Veterinary Pain Management Drugs by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Veterinary Clinics
  17. 2.4.3 Veterinary Hospitals
  18. 2.4.4 For Retail
  19. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Injected Veterinary Pain Management Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Injected Veterinary Pain Management Drugs Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Injected Veterinary Pain Management Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Injected Veterinary Pain Management Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Injected Veterinary Pain Management Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Injected Veterinary Pain Management Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Injected Veterinary Pain Management Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Injected Veterinary Pain Management Drugs, Established Date
  9. 3.9 Global Injected Veterinary Pain Management Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zoetis
  2. 4.1.1 Zoetis Company Information
  3. 4.1.2 Zoetis Business Overview
  4. 4.1.3 Zoetis Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zoetis Injected Veterinary Pain Management Drugs Product Portfolio
  6. 4.1.5 Zoetis Recent Developments
  7. 4.2 Merck & Co
  8. 4.2.1 Merck & Co Company Information
  9. 4.2.2 Merck & Co Business Overview
  10. 4.2.3 Merck & Co Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Merck & Co Injected Veterinary Pain Management Drugs Product Portfolio
  12. 4.2.5 Merck & Co Recent Developments
  13. 4.3 Medtronic
  14. 4.3.1 Medtronic Company Information
  15. 4.3.2 Medtronic Business Overview
  16. 4.3.3 Medtronic Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Medtronic Injected Veterinary Pain Management Drugs Product Portfolio
  18. 4.3.5 Medtronic Recent Developments
  19. 4.4 Lilly
  20. 4.4.1 Lilly Company Information
  21. 4.4.2 Lilly Business Overview
  22. 4.4.3 Lilly Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Lilly Injected Veterinary Pain Management Drugs Product Portfolio
  24. 4.4.5 Lilly Recent Developments
  25. 4.5 Baxter
  26. 4.5.1 Baxter Company Information
  27. 4.5.2 Baxter Business Overview
  28. 4.5.3 Baxter Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Baxter Injected Veterinary Pain Management Drugs Product Portfolio
  30. 4.5.5 Baxter Recent Developments
  31. 4.6 Norbrook Laboratories
  32. 4.6.1 Norbrook Laboratories Company Information
  33. 4.6.2 Norbrook Laboratories Business Overview
  34. 4.6.3 Norbrook Laboratories Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Norbrook Laboratories Injected Veterinary Pain Management Drugs Product Portfolio
  36. 4.6.5 Norbrook Laboratories Recent Developments
  37. 4.7 Halyard
  38. 4.7.1 Halyard Company Information
  39. 4.7.2 Halyard Business Overview
  40. 4.7.3 Halyard Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Halyard Injected Veterinary Pain Management Drugs Product Portfolio
  42. 4.7.5 Halyard Recent Developments
  43. 4.8 Forest Laboratories
  44. 4.8.1 Forest Laboratories Company Information
  45. 4.8.2 Forest Laboratories Business Overview
  46. 4.8.3 Forest Laboratories Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Forest Laboratories Injected Veterinary Pain Management Drugs Product Portfolio
  48. 4.8.5 Forest Laboratories Recent Developments
  49. 4.9 Endo International
  50. 4.9.1 Endo International Company Information
  51. 4.9.2 Endo International Business Overview
  52. 4.9.3 Endo International Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Endo International Injected Veterinary Pain Management Drugs Product Portfolio
  54. 4.9.5 Endo International Recent Developments
  55. 4.10 Elanco
  56. 4.10.1 Elanco Company Information
  57. 4.10.2 Elanco Business Overview
  58. 4.10.3 Elanco Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Elanco Injected Veterinary Pain Management Drugs Product Portfolio
  60. 4.10.5 Elanco Recent Developments
  61. 4.11 Ceva Sante Animale
  62. 4.11.1 Ceva Sante Animale Company Information
  63. 4.11.2 Ceva Sante Animale Business Overview
  64. 4.11.3 Ceva Sante Animale Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Ceva Sante Animale Injected Veterinary Pain Management Drugs Product Portfolio
  66. 4.11.5 Ceva Sante Animale Recent Developments
  67. 4.12 Bostonscientific
  68. 4.12.1 Bostonscientific Company Information
  69. 4.12.2 Bostonscientific Business Overview
  70. 4.12.3 Bostonscientific Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Bostonscientific Injected Veterinary Pain Management Drugs Product Portfolio
  72. 4.12.5 Bostonscientific Recent Developments
  73. 4.13 Boehringer Ingelheim
  74. 4.13.1 Boehringer Ingelheim Company Information
  75. 4.13.2 Boehringer Ingelheim Business Overview
  76. 4.13.3 Boehringer Ingelheim Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Boehringer Ingelheim Injected Veterinary Pain Management Drugs Product Portfolio
  78. 4.13.5 Boehringer Ingelheim Recent Developments
  79. 4.14 Bayer Pharma AG
  80. 4.14.1 Bayer Pharma AG Company Information
  81. 4.14.2 Bayer Pharma AG Business Overview
  82. 4.14.3 Bayer Pharma AG Injected Veterinary Pain Management Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bayer Pharma AG Injected Veterinary Pain Management Drugs Product Portfolio
  84. 4.14.5 Bayer Pharma AG Recent Developments
5 Global Injected Veterinary Pain Management Drugs Market Scenario by Region
  1. 5.1 Global Injected Veterinary Pain Management Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Injected Veterinary Pain Management Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Injected Veterinary Pain Management Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Injected Veterinary Pain Management Drugs Sales by Region: 2027-2032
  5. 5.3 Global Injected Veterinary Pain Management Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Injected Veterinary Pain Management Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Injected Veterinary Pain Management Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Injected Veterinary Pain Management Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Injected Veterinary Pain Management Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Injected Veterinary Pain Management Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Injected Veterinary Pain Management Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Injected Veterinary Pain Management Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Injected Veterinary Pain Management Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Injected Veterinary Pain Management Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Injected Veterinary Pain Management Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Injected Veterinary Pain Management Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Injected Veterinary Pain Management Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Injected Veterinary Pain Management Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Injected Veterinary Pain Management Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Injected Veterinary Pain Management Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Injected Veterinary Pain Management Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Injected Veterinary Pain Management Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Injected Veterinary Pain Management Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Injected Veterinary Pain Management Drugs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Injected Veterinary Pain Management Drugs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Injected Veterinary Pain Management Drugs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Injected Veterinary Pain Management Drugs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Injected Veterinary Pain Management Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Injected Veterinary Pain Management Drugs Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Injected Veterinary Pain Management Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Injected Veterinary Pain Management Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Injected Veterinary Pain Management Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Injected Veterinary Pain Management Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Injected Veterinary Pain Management Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Injected Veterinary Pain Management Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Injected Veterinary Pain Management Drugs Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Injected Veterinary Pain Management Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Injected Veterinary Pain Management Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Injected Veterinary Pain Management Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Injected Veterinary Pain Management Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Injected Veterinary Pain Management Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Injected Veterinary Pain Management Drugs Value Chain Analysis
  2. 8.1.1 Injected Veterinary Pain Management Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Injected Veterinary Pain Management Drugs Production Mode & Process
  5. 8.2 Injected Veterinary Pain Management Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Injected Veterinary Pain Management Drugs Distributors
  8. 8.2.3 Injected Veterinary Pain Management Drugs Customers
9 Global Injected Veterinary Pain Management Drugs Analyzing Market Dynamics
  1. 9.1 Injected Veterinary Pain Management Drugs Industry Trends
  2. 9.2 Injected Veterinary Pain Management Drugs Industry Drivers
  3. 9.3 Injected Veterinary Pain Management Drugs Industry Opportunities and Challenges
  4. 9.4 Injected Veterinary Pain Management Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst